In June 2017, a 46-year-old heart failure patient with a weight of 99 kg in the heart failure ward of the Chinese Academy of Medical Sciences Fuwai Hospital was unable to wait for a suitable heart transplant donor due to excessive weight, using an extracorporeal cardiopulmonary bypass device (ECMO). Supported the occurrence of hemodynamic instability after 14 days, life is at stake. On the 26th of the same month, the team of the academician Hu Shengshou of Fuwai Hospital passed the ethical examination and approval in the form of humanitarian exemption, and registered with the National and Beijing Municipal Health Planning Commission, and implemented the first third-generation full magnetic suspension artificial heart implant in China. Surgery. The patient was awake on the 2nd day after surgery, sat up on the 3rd day, started to go to the ground on the 4th day, completed a series of restorative treatment and training, and after repeated debugging of the equipment, the patient walked out of the hospital with an artificial heart. Returning to normal life, it has been more than 8 months now. It is understood that from June to October 2017, the team of Academician Hu Shengshou used the domestically produced third-generation all-magnetic suspension artificial heart with complete independent intellectual property rights to treat three critically ill patients under the premise of ethical examination and approval in the form of humanitarian exemption. Success, which marks the beginning of a new stage of development in the domestic artificial heart field. Fuwai Hospital has reached the international advanced level in the field of heart failure treatment, bringing new hope for the rejuvenation of patients with advanced heart failure. Heart failure is the end stage of the development of various types of heart disease and one of the leading causes of death in heart disease patients. The ventricular assist device, also known as the artificial heart, has become one of the standardized treatments for heart failure recommended by international guidelines. It has been one of the fastest growing areas for the treatment of severe heart disease in the past 10 years. At present, artificial heart mainly has three clinical applications: one is to wait for a heart transplant transition, to obtain more time for patients to wait for a suitable donor; the other is to provide short-term replacement support for patients with acute heart failure, to be removed after the recovery of cardiac function; The third is to provide long-term replacement for patients with end-stage heart failure, and support patients to carry artificial heart for long-term survival. The artificial heart is a sophisticated medical device that has undergone the first generation of large-volume blood flow devices in the 1990s, the second-generation axial flow devices in the early 21st century, and the latest third-generation magnetic levitation devices. The third-generation ventricular assist device is characterized by a magnetic suspension non-contact bearing, which has the advantages of small volume and good biocompatibility. Domestic third-generation full magnetic suspension artificial heart implant device and remote control appearance Since 2014, Suzhou Tongxin Medical Devices Co., Ltd. and the State Key Laboratory of Cardiovascular Disease have conducted in-depth research on the complete magnetic suspension technology of blood pump impellers, and closely combined with in vitro and in vivo test experiments to develop a prototype. Through 37 large animal experiments, the device was further optimized for anti-electromagnetic interference, pump operating temperature monitoring, blood compatibility, surgical operation tools and anticoagulation strategies, and completed the requirements of the China Food and Drug Control Research Institute in June 2017. Six of the 60 animals that survived for 60 days were reported for the experiment. At present, the product has entered the “fast track†for the special approval of national innovative medical devices. (Xinhua)
Chinese herbs have a long history, and we have thousands of years of experience and methods of using herbs. There are countless precious herbs on the land of China, which play a vital role in human life and health. High quality raw materials will benefit more people in today's world driven by modern science and technology. By adopting new modern high technology, the manufacturers extract and purify the essence of the valuable herbs to let more people could benifit it.
Natural herbs, originating from nature, are healthier and more assured. The herb extracts are very excellent raw materials for the health care products.
Our company, Allied, provides various herbal extracts, including ginger extract, pueraria root extract, black wolfberry extract, Angelica root extract, moringa leaf extract, honeysuckle extract, rhodiola rosea extract, Astragalus membranaceus extract, paeony root extract, black garlic powder, matcha powder, etc.
Besides the raw materials, we are also able to custom your own formula upon your unique requirements.
Natural healthy Herb Extracts, Health care product raw materials, black wolfberry extract Allied Extracts Solutions , https://www.alliedbiosolutions.com